A girl with major depressive disorder (MDD)

1002_SHSO_Transcranial Magnetic Stimulation (TMS) for the treatment of major depressive disorder (MDD)_EM

Description:

This lecture provides an evidence-based overview of transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder (MDD) in adolescents, with particular attention to youth with autism spectrum disorder (ASD). The presentation synthesizes current clinical trial data, the 2024 FDA clearance of TMS for adolescent depression, and the speaker’s recent publications on TMS for depression in ASD, and equips attendees with practical guidance on patient selection, safety, and counseling.

Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

Kirkbride, J. B., Anglin, D. M., Colman, I., Dykxhoorn, J., Jones, P. B., Patalay, P., Pitman, A., Soneson, E., Steare, T., Wright, T., & Griffiths, S. L. (2024). The social determinants of mental health and disorder: evidence, prevention and recommendations. World psychiatry : official journal of the World Psychiatric Association (WPA), 23(1), 58–90. https://doi.org/10.1002/wps.2116
Croarkin PE, Elmaghraby R, Nakonezny PA, et al. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a randomized sham-controlled trial. Neuropsychopharmacology. 2021;46(2):462–469.
Elmaghraby, R., Sun, Q., Ozger, C., Shekunov, J., Romanowicz, M., & Croarkin, P. E. (2022). A systematic review of the safety and tolerability of theta burst stimulation in children and adolescents. Neuromodulation: Technology at the Neural Interface, 25(4), 494-503
Blank, E., Gilbert, D. L., Wu, S. W., Larsh, T., Elmaghraby, R., Liu, R., ... & Pedapati, E. V. (2025). Accelerated theta burst transcranial magnetic stimulation for refractory depression in autism spectrum disorder. Journal of autism and developmental disorders, 55(3), 940-954.

Target Audience

Nurse Practitioner (NP)

Nurse, Registered (RN)

Physicians (MD or DO)

Physician Assistant (PA)

Psychologists

Social Workers

Learning Objectives

At the completion of this activity, learners will be able to:

1. Describe the current evidence base and 2024 FDA-cleared indications for TMS in adolescent major depressive disorder.

2. Apply criteria for appropriate patient selection for TMS among adolescents with MDD, including those with comorbid ASD.

3. Discuss TMS safety, tolerability, and procedural logistics with patients and families in a manner that addresses health disparities, implicit bias, and the communication and sensory needs of autistic youth.

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 Non-Physician Participation Credit
Sutter Health designates this Enduring activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
1.00 ANCC
Nursing Credit - American Nurses Credentialing Center (ANCC)
Sutter Health designates this Enduring activity for a maximum of 1.00 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ASWB-ACE
Social Work Credit
As a Jointly Accredited Organization, Sutter Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 continuing education credits.
1.00 CA BRN
Nursing Credit - California Board of Registered Nursing (CA BRN)
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Course opens:

06/10/2026

Course expires:

09/10/2026

Rating:

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

Matthew White, planner of System Behavioral Health Virtual Grand Rounds, has disclosed a financial relationship with an ineligible company Lief, in the form of stock ownership/stock options received in exchange for prior services. He is no longer actively engaged with the company. This relationship has been reviewed and mitigated in accordance with ACCME Standards for Integrity and Independence in Accredited Continuing Education.

No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.

– Provider Designee/Verification: Fozia Ferozali, Ed.D

Committee Member(s)